[Table, RESULTS]. - Neutropenic Sepsis: Prevention and Management of Neutropenic Sepsis in Cancer Patients

Antibiotic Group	Median proportion best	95% Credible intervals
Ureidopenicillins	0.83	0.83 to 1
3^rd Generation Cephalosporin	0.33	0.33 to 1
Carbapenem	0.17	0.17 to 0.83
4^th Generation Cephalosporin	0	0 to 0.67
Ureidopenicillins +aminoglycoside	0	0 to 0.83
3^rd Generation Cephalosporin +aminolycoside	0	0 to 0.83
4^th Generation Cephalosporin+aminoglycoside	0	0 to 1

Neutropenic Sepsis: Prevention and Management of Neutropenic Sepsis in Cancer Patients.

NICE Clinical Guidelines, No. 151.

National Collaborating Centre for Cancer (UK).

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.